ArticleProstate cancer2011

Bevacizumab and weekly docetaxel in patients with metastatic castrate-resistant prostate cancer previously exposed to docetaxel.

Filippo Francini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.